Plasma folate concentrations are positively associated with risk of estrogen receptor beta negative breast cancer in a Swedish nested case control study.

Folate's role in breast cancer development is controversial. Not only estrogen receptor (ER) alpha status, but also ERbeta status of tumors may have confounded results from previous epidemiological studies. We aimed to examine associations between plasma folate concentration and postmenopausal breast cancer defined by ER status. This nested case-control study, within the Malmö diet and cancer cohort, included 204 incident breast cancer cases with information on ERalpha and ERbeta status determined by immunochemistry on tissue micro-array sections. Plasma folate concentration was analyzed for the cases and 408 controls (matched on age and blood sample date). Odds ratios (OR) for ER-defined breast cancers in tertiles of plasma folate concentration were calculated with unconditional logistic regression. All tests were 2-sided. Women in the third tertile of plasma folate concentration (> 12 nmol/L) had higher incidence of ERbeta- breast cancer than women in the first tertile (OR: 2.67; 95% CI: 1.44-4.92; P-trend = 0.001). We did not observe significant associations between plasma folate concentration and other breast cancer subgroups defined by ER status. We observed a difference between risks for ERbeta + and ERbeta- cancer (P-heterogeneity = 0.003). Our findings, which indicate a positive association between plasma folate and ERbeta- breast cancer, highlight the importance of taking ERbeta status into consideration in studies of folate and breast cancer. The study contributes knowledge concerning folate's multifaceted role in cancer development. If replicated in other populations, the observations may have implications for public health, particularly regarding folic acid fortification.

[1]  W. Willett,et al.  A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. , 2009, The American journal of clinical nutrition.

[2]  J. Carlson,et al.  Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele. , 2009, The American journal of clinical nutrition.

[3]  J. Carlson,et al.  Folate Intake, Methylenetetrahydrofolate Reductase Polymorphisms, and Breast Cancer Risk in Women from the Malmö Diet and Cancer Cohort , 2009, Cancer Epidemiology Biomarkers & Prevention.

[4]  C. Ulrich,et al.  Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. , 2009, The American journal of clinical nutrition.

[5]  S. Larsson,et al.  Folate Intake and Risk of Breast Cancer by Estrogen and Progesterone Receptor Status in a Swedish Cohort , 2008, Cancer Epidemiology Biomarkers & Prevention.

[6]  E. Sonestedt,et al.  Plant foods and oestrogen receptor alpha- and beta-defined breast cancer: observations from the Malmo Diet and Cancer cohort. , 2008, Carcinogenesis.

[7]  J. Bai,et al.  Methylenetetrahydrofolate reductase gene polymorphisms in 13 Chinese ethnic populations , 2008, Cell biochemistry and function.

[8]  A. Smith,et al.  Is folic acid good for everyone? , 2008, The American journal of clinical nutrition.

[9]  R. Jain,et al.  Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. , 2007, The American journal of clinical nutrition.

[10]  K. Jirström,et al.  Oestrogen receptors α and β show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer , 2007, Journal of Clinical Pathology.

[11]  E. Sonestedt,et al.  High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmö Diet and Cancer cohort. , 2007, The American journal of clinical nutrition.

[12]  I. Rosenberg,et al.  A Temporal Association between Folic Acid Fortification and an Increase in Colorectal Cancer Rates May Be Illuminating Important Biological Principles: A Hypothesis , 2007, Cancer Epidemiology Biomarkers & Prevention.

[13]  S. Chanock,et al.  Genetic polymorphisms in the one‐carbon metabolism pathway and breast cancer risk: A population‐based case–control study and meta‐analyses , 2007, International journal of cancer.

[14]  Elizabeth L. Barry,et al.  Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. , 2007, JAMA.

[15]  S. Larsson,et al.  Folate and risk of breast cancer: a meta-analysis. , 2007, Journal of the National Cancer Institute.

[16]  Y.-I. Kim,et al.  Folate: a magic bullet or a double edged sword for colorectal cancer prevention? , 2006, Gut.

[17]  R. Hoover,et al.  Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. , 2006, The American journal of clinical nutrition.

[18]  Young-In Kim.  Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. , 2005, The Journal of nutrition.

[19]  M. C. Archer,et al.  Effects of dietary folate on the development and progression of mammary tumors in rats. , 2005, Carcinogenesis.

[20]  W. Willett,et al.  Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status , 2005, Cancer Epidemiology Biomarkers & Prevention.

[21]  C. Pfeiffer,et al.  Measurement of folates in serum and conventionally prepared whole blood lysates: application of an automated 96-well plate isotope-dilution tandem mass spectrometry method. , 2004, Clinical chemistry.

[22]  H. Boeing,et al.  Plasma folate as marker of folate status in epidemiological studies: the European Investigation into Cancer and Nutrition (EPIC)-Potsdam study , 2004, British Journal of Nutrition.

[23]  V. Speirs,et al.  Oestrogen receptor β: what it means for patients with breast cancer , 2004 .

[24]  Scott M. Williams,et al.  Methyl-group dietary intake and risk of breast cancer among African-American women: a case–control study by methylation status of the estrogen receptor alpha genes , 2003, Cancer Causes & Control.

[25]  E. Lam,et al.  Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. , 2003, Oncogene.

[26]  V. Speirs,et al.  Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model , 2003, The Journal of pathology.

[27]  C. McKerlie,et al.  Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. , 2003, Carcinogenesis.

[28]  J. Mason,et al.  Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. , 2003, The Journal of nutrition.

[29]  G. Berglund,et al.  Nutrition Journal a Methodological Report from the Malmö Diet and Cancer Study: Development and Evaluation of Altered Routines in Dietary Data Processing , 2022 .

[30]  Janet E Olson,et al.  Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  D. Hunter,et al.  Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. , 2002, Pharmacogenetics.

[32]  K. Blennow,et al.  Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos , 2002, European Journal of Human Genetics.

[33]  G. Berglund,et al.  The Malmö diet and cancer study: representativity, cancer incidence and mortality in participants and non‐participants , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[34]  A. Traish,et al.  Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor α and β , 2001, Steroids.

[35]  G. Berglund,et al.  Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. , 2000, American journal of epidemiology.

[36]  L. Moore,et al.  Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. , 1999, Cancer research.

[37]  P. Wilson,et al.  The effect of folic acid fortification on plasma folate and total homocysteine concentrations. , 1999, The New England journal of medicine.

[38]  Scott M. Williams,et al.  Methyl-deficient diets, methylated ER genes and breast cancer: An hypothesized association , 1998, Cancer Causes & Control.

[39]  F. Gabreëls,et al.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.

[40]  B. Ames,et al.  Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.

[42]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  E. Riboli,et al.  Dietary assessment methods evaluated in the Malmö food study , 1993, Journal of internal medicine.

[44]  G. Berglund,et al.  The Malmö biological bank , 1993, Journal of internal medicine.

[45]  I. Eto,et al.  Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. , 1992, Journal of the National Cancer Institute.

[46]  Meir J. Stampfer,et al.  Total energy intake: implications for epidemiologic analyses. , 1986, American journal of epidemiology.

[47]  C. Mph.  Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women , 2009 .

[48]  C. Ulrich,et al.  Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. , 2006, The Journal of nutrition.

[49]  V. Speirs,et al.  Oestrogen receptor beta: what it means for patients with breast cancer. , 2004, The Lancet. Oncology.

[50]  A. Traish,et al.  Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta. , 2001, Steroids.

[51]  E Riboli,et al.  The Malmö Food Study: validity of two dietary assessment methods for measuring nutrient intake. , 1997, International journal of epidemiology.